| abstract |
The present invention refers to the use of lipase inhibitors, e.g. orlistat, for the manufacture of medicaments for treating, reducing or preventing functional dyspepsia, e.g. intensity of stomach fullness, nausea, bloating after ingestion of small or larger meal, especially of fat containing or fat rich meals, and the medicaments thus manufactured. |